S5S1 or S2 or S3 or S4
S4( candesartan or losartan or valsartan or eprosartan or irbesartan or olmesartan or telmisartan or ARB or ARBS ) or angiotensin receptor N3 antagonist* or angiotensin receptor N3 blocker*
S3(MH "Angiotensin II Type I Receptor Blockers+")
S2( captopril or cilazipril or enalapril or fosinopril or imidapril or lisinopril or moexipril or perindopril or coversyl or quinapril or ramipril or trandolapril ) or angiotensin-converting enzyme N2 inhibitor* or ACE N2 inhibitor*
S1(MH "Angiotensin-Converting Enzyme Inhibitors+")

From: Appendix D, Literature search strategies

Cover of Stable Angina
Stable Angina: Methods, Evidence & Guidance [Internet].
NICE Clinical Guidelines, No. 126.
National Clinical Guidelines Centre (UK).
Copyright © 2011, National Clinical Guidelines Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of the National Clinical Guidelines Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.